Rx GHK-Cu explains published studies about a copper-bound peptide.

Rx GHK-Cu is a study guide, not a clinic

Rx GHK-Cu explains published research on the copper peptide GHK-Cu. Study readers, not a doctor or clinic, write these pages.

The site does not diagnose illness, plan care, or sell a product. It explains published findings and names the questions those studies leave open.

Here, 'Rx' belongs to the site name alone. It does not mean anyone here writes or fills a prescription.

The name is not backed by a pharmacy. Nothing on this site is offered for sale.

You can trace each number to a study

Each number was matched to the paper named beside it. Doses, percentages, and measured changes carry a numbered source.

Before a paper was used, its claim and number were checked together. The references page gives its title and a free government link.

Those links may list the paper or show the full text. You don't need them to follow the plain summary.

The gaps appear here too. Human proof is mostly small skin trials; much other work used cells or rodents.

Human trials have not tracked injected GHK-Cu over time. One team wrote many early papers.

Rx GHK-Cu cannot give medical advice

This site is not medical advice, a care plan, or a dose guide. It does not tell any person to take GHK-Cu by any route.

Study amounts describe only what a given test used. They don't become a human dose.

For no illness is GHK-Cu an FDA- or EMA-approved drug. Skin products may contain Copper Tripeptide-1, while shots and whole-body forms remain unapproved.

Your health choices belong with a skilled health worker who knows your full history. A website cannot know that history.